IN2012DN04917A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN04917A IN2012DN04917A IN4917DEN2012A IN2012DN04917A IN 2012DN04917 A IN2012DN04917 A IN 2012DN04917A IN 4917DEN2012 A IN4917DEN2012 A IN 4917DEN2012A IN 2012DN04917 A IN2012DN04917 A IN 2012DN04917A
- Authority
- IN
- India
- Prior art keywords
- compounds
- imidazo
- methods
- disclosed
- pyridine
- Prior art date
Links
- 238000000034 method Methods 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000005234 imidazo[1,2-a]pyridines Chemical class 0.000 abstract 2
- 241000196324 Embryophyta Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 150000005232 imidazopyridines Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- 201000008827 tuberculosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pulmonology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25854909P | 2009-11-05 | 2009-11-05 | |
| PCT/US2010/055728 WO2011057145A2 (en) | 2009-11-05 | 2010-11-05 | Imidazo[1,2-a] pyridine compounds, synthesis thereof, and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN04917A true IN2012DN04917A (hu) | 2015-09-25 |
Family
ID=43970798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN4917DEN2012 IN2012DN04917A (hu) | 2009-11-05 | 2010-11-05 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US9309238B2 (hu) |
| EP (2) | EP3257854A1 (hu) |
| CN (3) | CN106866667B (hu) |
| BR (1) | BR112012010752B1 (hu) |
| HK (1) | HK1248676A1 (hu) |
| IL (1) | IL219564A (hu) |
| IN (1) | IN2012DN04917A (hu) |
| RU (1) | RU2608611C2 (hu) |
| WO (1) | WO2011057145A2 (hu) |
| ZA (1) | ZA201204028B (hu) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3257854A1 (en) * | 2009-11-05 | 2017-12-20 | University of Notre Dame du Lac | Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same |
| CA2793086C (en) * | 2010-03-18 | 2018-08-21 | Institut Pasteur Korea | Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections |
| WO2012105594A1 (ja) | 2011-02-01 | 2012-08-09 | 協和発酵キリン株式会社 | 縮環複素環誘導体 |
| KR102104125B1 (ko) | 2011-04-21 | 2020-05-29 | 재단법인 한국파스퇴르연구소 | 소염 화합물 |
| JP2014530850A (ja) | 2011-10-21 | 2014-11-20 | トレント・ファーマシューティカルズ・リミテッドＴｏｒｒｅｎｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ | Ｇｐｂａｒ１受容体調節剤としての新規置換イミダゾピリミジン |
| CN104619707A (zh) | 2012-07-31 | 2015-05-13 | 协和发酵麒麟株式会社 | 稠环杂环化合物 |
| US20160185774A1 (en) * | 2013-08-02 | 2016-06-30 | Institut Pasteur Korea | Anti-Infective Compounds |
| WO2015143652A1 (en) * | 2014-03-26 | 2015-10-01 | Merck Sharp & Dohme Corp. | TrkA KINASE INHIBITORS,COMPOSITIONS AND METHODS THEREOF |
| CN103965193B (zh) * | 2014-05-30 | 2016-04-06 | 浙江司太立制药股份有限公司 | N-(苯氧烷基)咪唑并[1,2-a]吡啶-3-酰胺类化合物及其制备方法 |
| CN104628721A (zh) * | 2015-01-22 | 2015-05-20 | 湖南华腾制药有限公司 | 一种咪唑并[1,2-a]吡啶衍生物的制备方法 |
| CN108235704B (zh) | 2015-07-02 | 2021-10-26 | 爱尔兰詹森科学公司 | 抗细菌化合物 |
| PE20181352A1 (es) * | 2015-09-17 | 2018-08-22 | Marvin J Miller | Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias |
| BR112018075939A2 (pt) * | 2016-06-16 | 2019-04-09 | Janssen Sciences Ireland Unlimited Company | compostos heterocíclicos como antibacterianos |
| MA45377A (fr) | 2016-06-16 | 2019-04-24 | Janssen Sciences Ireland Unlimited Co | Composés hétérocycliques en tant qu'agents antibacteriens |
| CN106588916A (zh) * | 2016-11-21 | 2017-04-26 | 浙江司太立制药股份有限公司 | N‑(苯氧乙基)咪唑并[1,2‑a]吡啶‑3‑酰胺类化合物及其制备方法 |
| KR20190093648A (ko) * | 2016-12-16 | 2019-08-09 | 바이엘 악티엔게젤샤프트 | 살곤충제로서 사용하기 위한 메소이온성 이미다조피리딘 |
| EP4417262A3 (en) | 2017-03-01 | 2024-11-27 | Janssen Sciences Ireland Unlimited Company | Combination therapy |
| CN108159049B (zh) * | 2018-02-01 | 2021-01-05 | 中国科学院广州生物医药与健康研究院 | 一种吡啶类化合物的新用途 |
| US20210009583A1 (en) * | 2018-03-12 | 2021-01-14 | University Of Notre Dame Du Lac | Deuterated imidazopyridines |
| CN110759913B (zh) * | 2018-07-26 | 2022-01-28 | 南开大学 | 吲哚酰腙衍生物及其制备方法和在防治植物病毒、杀菌、杀虫方面的应用 |
| CN113480541B (zh) * | 2019-03-07 | 2022-09-02 | 湖南化工研究院有限公司 | 咪唑并吡啶化合物及其中间体的制备方法 |
| US20220151236A1 (en) * | 2019-04-08 | 2022-05-19 | Pi Industries Ltd. | Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi |
| TWI861208B (zh) | 2019-09-10 | 2024-11-11 | 日商鹽野義製藥股份有限公司 | 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物 |
| CN115073454B (zh) * | 2022-08-09 | 2024-03-08 | 贵州大学 | 一种咪唑并吡啶-2-噁唑啉类化合物及其制备方法和应用 |
| EP4658638A1 (en) * | 2023-02-02 | 2025-12-10 | Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) | Small molecules for the treatment of mycobacterial diseases |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2525602A1 (fr) * | 1982-04-21 | 1983-10-28 | Synthelabo | Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique |
| ZA839398B (en) * | 1982-12-27 | 1985-08-28 | Lilly Co Eli | Substituted imidazopyrimidines-pyrazines,and-triazines |
| FR2593818B1 (fr) * | 1986-02-05 | 1988-04-29 | Synthelabo | Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridine, leur preparation et leur application en therapeutique |
| DE4010797A1 (de) | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
| DE4023215A1 (de) | 1990-07-21 | 1992-01-23 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung |
| JPH0539205A (ja) | 1990-12-21 | 1993-02-19 | Takeda Chem Ind Ltd | 農園芸用混合組成物 |
| JP3026845B2 (ja) | 1991-02-20 | 2000-03-27 | 日清製粉株式会社 | ピペリジン誘導体 |
| US5464843A (en) | 1992-06-23 | 1995-11-07 | G.D. Searle & Co. | Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury |
| US5721273A (en) * | 1993-12-15 | 1998-02-24 | Alcon Laboratories, Inc. | Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension |
| WO1995028389A1 (en) | 1994-04-15 | 1995-10-26 | Yamanouchi Pharmaceutical Co., Ltd. | Spiro compound and medicinal composition thereof |
| EP0771319A1 (en) | 1994-07-15 | 1997-05-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
| US6323227B1 (en) | 1996-01-02 | 2001-11-27 | Aventis Pharmaceuticals Products Inc. | Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| US6080767A (en) | 1996-01-02 | 2000-06-27 | Aventis Pharmaceuticals Products Inc. | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| JPH09249666A (ja) | 1996-01-12 | 1997-09-22 | Takeda Chem Ind Ltd | 三環性化合物の製造法およびその中間体 |
| SE9700661D0 (sv) * | 1997-02-25 | 1997-02-25 | Astra Ab | New compounds |
| AUPP278498A0 (en) * | 1998-04-03 | 1998-04-30 | Australian Nuclear Science & Technology Organisation | Peripheral benzodiazepine receptor binding agents |
| US6288234B1 (en) | 1998-06-08 | 2001-09-11 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
| GB2351081A (en) | 1999-06-18 | 2000-12-20 | Lilly Forschung Gmbh | Pharmaceutically active imidazoline compounds and analogues thereof |
| US6632815B2 (en) | 1999-09-17 | 2003-10-14 | Millennium Pharmaceuticals, Inc. | Inhibitors of factor Xa |
| NZ517828A (en) | 1999-09-17 | 2003-10-31 | Millennium Pharm Inc | Inhibitors having activity against mammalian factor Xa |
| US6403588B1 (en) * | 2000-04-27 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
| CA2407573C (en) | 2000-04-27 | 2011-09-13 | Yamanouchi Pharmaceutical Co. Ltd. | Imidazopyridine derivatives |
| US6552037B2 (en) * | 2000-06-30 | 2003-04-22 | Neurogen Corporation | 2-Substituted imidazo[1,2-A]pyridine derivatives |
| GB0021670D0 (en) * | 2000-09-04 | 2000-10-18 | Astrazeneca Ab | Chemical compounds |
| DE10247269A1 (de) * | 2002-10-10 | 2004-04-22 | Grünenthal GmbH | Substituierte C-Imidazo[1,2-a]pyridin-3-yl-methylamine |
| WO2004100868A2 (en) | 2003-04-23 | 2004-11-25 | Abbott Laboratories | Method of treating transplant rejection |
| WO2005063739A1 (en) | 2003-12-23 | 2005-07-14 | Pfizer Inc. | Novel quinoline derivatives |
| WO2005108399A1 (ja) * | 2004-05-10 | 2005-11-17 | Banyu Pharmaceutical Co., Ltd. | イミダゾピリジン化合物 |
| US20060084806A1 (en) * | 2004-07-21 | 2006-04-20 | Ramasubramanian Sridharan | Processes for the preparation of imidazo[1,2-a] pyridine derivatives |
| US20080051409A1 (en) * | 2004-08-02 | 2008-02-28 | Peter Gmeiner | Indolizine Carboxamides and Aza and Diaza Derivatives Thereof |
| RU2007121864A (ru) * | 2004-11-11 | 2008-12-20 | Феррер Интернасионал | ИМИДАЗО[1,2-a]ПИРИДИНОВЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ), КОМПОЗИЦИЯ НА ИХ ОСНОВЕ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ РЕЦЕПТОРОВ GABAA, ИЛИ α1-GABAA, ИЛИ α2-GABAA (ВАРИАНТЫ) |
| US7786115B2 (en) * | 2004-12-24 | 2010-08-31 | Astrazeneca Ab | Amide derivatives |
| WO2007015866A2 (en) | 2005-07-20 | 2007-02-08 | Kalypsys, Inc. | Inhibitors of p38 kinase and methods of treating inflammatory disorders |
| AU2007254361A1 (en) | 2006-05-18 | 2007-11-29 | Merck Sharp & Dohme Corp. | Substituted esters as Cannabinoid-1 receptor modulators |
| FR2903178B1 (fr) | 2006-07-03 | 2008-10-03 | Rech S De L Ecole Nationale Su | Procede et dispositif de nettoyage des surfaces de ruissellement d'eau dans un echangeur thermique air/eau |
| ES2350460T3 (es) * | 2006-09-29 | 2011-01-24 | Actelion Pharmaceuticals Ltd. | Derivados de 3-aza-biciclo[3.1.0]hexano. |
| CA2665214A1 (en) * | 2006-10-06 | 2008-05-29 | Abbott Laboratories | Novel imidazothiazoles and imidazoxazoles |
| CA2672960A1 (en) * | 2006-12-20 | 2008-07-10 | Schering Corporation | Novel jnk inhibitors |
| MX2009009540A (es) | 2007-03-07 | 2009-09-16 | Alantos Pharm Holding | Inhibidores de metaloproteasa que contienen una porcion heterociclica. |
| EP1980251A1 (en) * | 2007-04-13 | 2008-10-15 | Glaxo Group Limited | Pyrrolo[3,2,1-ij]quinoline-4-one derivatives for treating tuberculosis |
| CL2008001631A1 (es) | 2007-06-06 | 2009-01-02 | Smithkline Beecham Corp | Compuestos derivados de heterociclos sustituidos, con la presencia de un grupo fenoxi, inhibidores de transcriptasa inversa; composicion farmaceutica; y uso en el tratamiento de infecciones virales por vih. |
| EP2200440B1 (en) * | 2007-07-23 | 2017-07-19 | Crestone, Inc. | Antibacterial amide and sulfonamide substituted heterocyclic urea compounds |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| AU2009249186B2 (en) * | 2008-05-19 | 2014-05-22 | Sunovion Pharmaceuticals Inc. | Imidazo [1, 2-a] pyridine compounds as GABA-A receptor modulators |
| WO2009148961A2 (en) | 2008-05-29 | 2009-12-10 | Wisconsin Alumni Research Foundation | Drugs to prevent hpv infection |
| JP5536773B2 (ja) | 2008-08-14 | 2014-07-02 | ベータ・ファーマ・カナダ・インコーポレイテッド | Ｅｐ４受容体アンタゴニストとしてのヘテロ環式アミド誘導体 |
| US8198449B2 (en) * | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| US8293909B2 (en) | 2008-09-11 | 2012-10-23 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
| DK2376490T3 (da) * | 2008-12-04 | 2013-04-15 | Proximagen Ltd | Imidazopyridinforbindelser |
| WO2011050245A1 (en) | 2009-10-23 | 2011-04-28 | Yangbo Feng | Bicyclic heteroaryls as kinase inhibitors |
| EP3257854A1 (en) * | 2009-11-05 | 2017-12-20 | University of Notre Dame du Lac | Imidazo[1,2-a]pyridine compounds, synthesis thereof, and methods of using same |
| CA2793086C (en) | 2010-03-18 | 2018-08-21 | Institut Pasteur Korea | Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections |
-
2010
- 2010-11-05 EP EP17168780.9A patent/EP3257854A1/en not_active Withdrawn
- 2010-11-05 CN CN201710222577.0A patent/CN106866667B/zh active Active
- 2010-11-05 CN CN201080060716.0A patent/CN102762556B/zh active Active
- 2010-11-05 BR BR112012010752-6A patent/BR112012010752B1/pt active IP Right Grant
- 2010-11-05 WO PCT/US2010/055728 patent/WO2011057145A2/en not_active Ceased
- 2010-11-05 IN IN4917DEN2012 patent/IN2012DN04917A/en unknown
- 2010-11-05 US US13/508,011 patent/US9309238B2/en active Active
- 2010-11-05 EP EP10829196.4A patent/EP2496578A4/en not_active Withdrawn
- 2010-11-05 CN CN201910419228.7A patent/CN110483499A/zh active Pending
- 2010-11-05 RU RU2012122653A patent/RU2608611C2/ru active
-
2012
- 2012-05-03 IL IL219564A patent/IL219564A/en active IP Right Grant
- 2012-06-01 ZA ZA2012/04028A patent/ZA201204028B/en unknown
-
2016
- 2016-02-29 US US15/056,630 patent/US9908876B2/en active Active
-
2018
- 2018-02-05 US US15/888,605 patent/US10913737B2/en active Active
- 2018-06-20 HK HK18107921.9A patent/HK1248676A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN106866667B (zh) | 2019-11-15 |
| RU2608611C2 (ru) | 2017-01-23 |
| US9908876B2 (en) | 2018-03-06 |
| HK1248676A1 (en) | 2018-10-19 |
| CN110483499A (zh) | 2019-11-22 |
| ZA201204028B (en) | 2013-11-27 |
| RU2012122653A (ru) | 2013-12-10 |
| US20120220457A1 (en) | 2012-08-30 |
| CN102762556B (zh) | 2017-04-26 |
| CN102762556A (zh) | 2012-10-31 |
| US20180354944A1 (en) | 2018-12-13 |
| WO2011057145A3 (en) | 2011-09-09 |
| EP2496578A2 (en) | 2012-09-12 |
| BR112012010752B1 (pt) | 2021-07-20 |
| IL219564A0 (en) | 2012-06-28 |
| CN106866667A (zh) | 2017-06-20 |
| US20160318925A1 (en) | 2016-11-03 |
| BR112012010752A2 (pt) | 2020-09-15 |
| US9309238B2 (en) | 2016-04-12 |
| US10913737B2 (en) | 2021-02-09 |
| WO2011057145A2 (en) | 2011-05-12 |
| IL219564A (en) | 2017-01-31 |
| EP2496578A4 (en) | 2013-08-21 |
| EP3257854A1 (en) | 2017-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN04917A (hu) | ||
| MX2009010728A (es) | Compuestos de imidazo[1,2-a]piridina como inhibidores de la tirosina-cinasa repectora. | |
| MX358682B (es) | Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4). | |
| WO2012007345A3 (en) | Substituted imidazo[1,2-a]pyrimidines and -pyridines | |
| TNSN07323A1 (en) | Imidazo (1, 2-a) pyridine compounds as vegf-r2 inhibitors | |
| IL187586A0 (en) | Method for producing dihydroquinazolines | |
| TW200736260A (en) | Inhibitors of Akt activity | |
| WO2006136357A3 (de) | Kristalline modifikationen des pyraclostrobins | |
| WO2011101069A3 (en) | 1, 8 -naphthyridines as kinase inhibitors | |
| EP2142543B8 (en) | Pyrido [2, 3-d]pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| AP2492A (en) | Novel compositions of fungal inocula, method for the preparation thereof and use thereof for improving the growth of cultures | |
| MX2011008452A (es) | Derivados de triazolo [4,3-b] piridazina y sus usos para el cancer de prostata. | |
| MX2009007436A (es) | Derivados espirociclicos de acido tetronico. | |
| IL201209A0 (en) | Pyrido [2, 3 - d] pyrimidin - 7 - one compounds as inhibitors of pi3k - alpha for the treatment of cancer | |
| WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
| PH12014500317A1 (en) | Antibacterial cyclopenta[c]pyrrole substituted 3,4-dihydro-1h-[1,8]naphthyridinones | |
| WO2008140641A3 (en) | Pure paliperidone and processes for preparing thereof | |
| WO2008021346A3 (en) | Pure paliperidone and processes for preparing thereof | |
| TW200700064A (en) | Novel compounds | |
| MX2010002477A (es) | Perharidinas como inhibidores de cdk. | |
| TW200716110A (en) | Inhibitors of AKT activity | |
| GB0508314D0 (en) | Organic compounds | |
| WO2009047634A3 (en) | Aqueous formulations of acetaminophen for injection | |
| WO2007079119A3 (en) | Process for manufacturing picolinate borinic esters |